Select Page

Universal Access and Affordable Medicines

Our campaign promotes transparency, accountability and the public interest in the field of pharmaceuticals. Our evidence-based advocacy aims to guarantee better and affordable medicines for Europe by questioning and reforming the current pharmaceutical business model and calling for better access to medicines for all.

About our work on access to medicines


EPHA Response to public consultation on EMA Regulatory Science to 2025

Getting it right: how to improve the European Commission proposal on HTA

Recommendations on a new model for the provision of scientific advice

Latest Developments

Analysis & Opinion

Get monthly updates on key public health issues!


Time for a new deal

14 November 2019

4th EPHA Universal Access and Affordable Medicines Forum. Challenging the status quo on medicines policy.

Past events

Putting health first

3 June 2019

Trailblazers, routes to better and affordable medicines by 2025

20 November 2018

How good are our medicines?

3 October 2018

Game changers for better and affordable medicines in Europe

21 November 2017

Do you have a question?

Meet our Universal Access and Affordable Medicines Policy Lead.

Yannis Natsis

Policy Manager
+32 2 233 3886

© 2019 - Development by Simpl.


We publish our newsletter ten times a year to keep you informed about the latest news on public health in Europe. You can receive it directly in your mailbox.
First Name
Last Name
Email address
Secure and Spam free...